Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide

被引:0
|
作者
Sandra Coral
Giulia Parisi
Hugues J. M. G. Nicolay
Francesca Colizzi
Riccardo Danielli
Elisabetta Fratta
Alessia Covre
Pietro Taverna
Luca Sigalotti
Michele Maio
机构
[1] Centro di Riferimento Oncologico,Cancer Bioimmunotherapy Unit
[2] Istituto Toscano Tumori,Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena
[3] Astex Pharmaceuticals,undefined
[4] Inc.,undefined
来源
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词
DNA hypomethylating agent; Cancer; Immunotherapy; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:605 / 614
页数:9
相关论文
共 50 条
  • [21] Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine
    Lemaire, Maryse
    Momparler, Louise F.
    Raynal, Noel J. -M.
    Bernstein, Mark L.
    Momparler, Richard L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 411 - 416
  • [22] The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
    Almstedt, Maika
    Blagitko-Dorfs, Nadja
    Duque-Afonso, Jesus
    Karbach, Julia
    Pfeifer, Dietmar
    Jaeger, Elke
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2010, 34 (07) : 899 - 905
  • [23] A 5-aza-2′-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma
    Leclercq, S.
    Gueugnon, F.
    Boutin, B.
    Guillot, F.
    Blanquart, C.
    Rogel, A.
    Padieu, M.
    Pouliquen, D.
    Fonteneau, J-F.
    Gregoire, M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (05) : 1105 - 1116
  • [24] Genome-Wide Demethylation by 5-aza-2′-Deoxycytidine Alters the Cell Fate of Stem/Progenitor Cells
    Zhou, Yang
    Hu, Zhengqing
    STEM CELL REVIEWS AND REPORTS, 2015, 11 (01) : 87 - 95
  • [25] Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine
    Ding, Xiao-Lei
    Yang, Xiaojing
    Liang, Gangning
    Wang, Kai
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine
    Daurkin, Irina
    Eruslanov, Evgeniy
    Vieweg, Johannes
    Kusmartsev, Sergei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (05) : 697 - 706
  • [27] Gene expression profiling of the synergy of 5-aza-2′-deoxycytidine and paclitaxel against renal cell carcinoma
    Han, Tiandong
    Shang, Donghao
    Xu, Xiuhong
    Tian, Ye
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [28] Resistance to 5-aza-2′-deoxycytidine in Genic Regions Compared to Non-genic Repetitive Sequences
    Lim, Hui Wen
    Iwatani, Misa
    Hattori, Naoko
    Tanaka, Satoshi
    Yagi, Shintaro
    Shiota, Kunio
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2010, 56 (01) : 86 - 93
  • [29] 5-Aza-2′-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer)
    Dai, Zunyan
    Liu, Shujun
    Marcucci, Guido
    Sadee, Wolfgang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (02) : 455 - 461
  • [30] Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2′-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C
    Momparler, Richard L.
    Cote, Sylvie
    Momparler, Louise F.
    EPIGENOMES, 2021, 5 (02)